manufacturers were issued an approved manufacturing quota that was higher than the quota issued to that manufacturer for that substance in the previous year. (3) Not later than 180 days after the date of enactment of this subsection, the Attorney General shall submit to Congress a report on how the Attorney General will ensure that the annual process of fixing and adjusting production and manufacturing quotas under this section takes into consideration— (A) efforts to reduce the costs, injuries, and deaths associated with the diversion and abuse of prescription opioids and heroin, including changes in the accepted medical use of certain controlled substances